Capricor Therapeutics (CAPR) Depreciation and Depletion (2015 - 2026)

Capricor Therapeutics' Depreciation and Depletion history runs 12 years deep, the most recent figure standing at $534670.0 for Q1 2026.

• In Q1 2026, Depreciation and Depletion rose 31.87% year-over-year to $534670.0; the TTM figure through Mar 2026 stood at $2.0 million (up 34.62% YoY), while the FY2025 annual figure was $1.9 million, up 32.54% from the prior year.
• Depreciation and Depletion was $534670.0 for Q1 2026 at Capricor Therapeutics, up from $502587.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $534670.0 in Q1 2026 to a low of $92490.0 in Q1 2022.
• Historically, Depreciation and Depletion has averaged $320643.3 across 5 years, with a median of $331406.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Depreciation and Depletion surged 148.78% in 2023, then climbed 22.14% in 2024.
• A 5-year view of Depreciation and Depletion shows it stood at $191602.0 in 2022, then soared by 60.55% to $307608.0 in 2023, then advanced by 22.14% to $375705.0 in 2024, then surged by 33.77% to $502587.0 in 2025, then gained by 6.38% to $534670.0 in 2026.
• The last three Depreciation and Depletion figures came in at $534670.0 (Q1 2026), $502587.0 (Q4 2025), and $494725.0 (Q3 2025), per Business Quant data.